Prostaglandin E2 is the major arachidonic acid metabolite secreted by esophageal mucosal cells in rabbits

Inflammation

Volumn 21, Issue 4, 1997, Pages 419-429

  Jiménez, Pilar ^a   Lanas, Angel ^a   Piazuelo, Elena ^a   Bioque, Gloria ^b   Esteva, Francisco ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b Dpto Bioanalítica Medico   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CALCIMYCIN; CYTOKERATIN; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; INTERLEUKIN 1BETA; LEUKOTRIENE; LIPOXYGENASE; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; 6 OXOPROSTAGLANDIN F1 ALPHA; INDOMETACIN; INTERLEUKIN 1; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; ESOPHAGUS MUCOSA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MUCOSA CELL; NONHUMAN; PROSTAGLANDIN RELEASE; RABBIT; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; ESOPHAGUS; METABOLISM; MUCOSA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ARACHIDONIC ACID; CALCIMYCIN; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ESOPHAGUS; INDOMETHACIN; INTERLEUKIN-1; LIPOXYGENASE INHIBITORS; MUCOUS MEMBRANE; NORDIHYDROGUAIARETIC ACID; RABBITS;

EID: 0030610664     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027318520752     Document Type: Article

References (25)

1. SOLI, A. H., W. M. WEINSTEIN, J. KURATA, and D. MCCARTHY. 1991. Nonsteroidal antiinflammatory drugs and peptic ulcer disease. UCLA Conference. Ann. Intern. Med. 114:307-309.
2. GRAHAM, D. Y, N. M. AGRAWAL, and S. H. ROTH. 1988. Prevention of NSAID-induced gastric ulcer with misoprostol: a multicenter, double-blind, placebo controlled trial. Lancet 2:1277-1280.
3. BJARNASON, I., I. HAYLLAR, A. J. MACPHERSON, and A. S. RUSSEL. 1993. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroentrology 104:1832-1847.
4. KIKENDALL, J. W. 1991. Pill-induced esophageal injury. Gastroenterol Clin. North. Am. 20:835-846.
5. MORGAN, G. P., and J. G. WILLIANS. 1994. Inflammatory mediators in the esophagus. Gut 35:297-298.
6. EASTWOOD, G. L., B. D. BECK, D. O. CASTELL, F. C. BROWN, and J. R. FLETCHER. 1981. Beneficial effect of indomethacin on acid-induced esophagitis in cats. Dig. Dis. Sci. 26:601-608.
7. NORTHWAY, M. G., H. I. LIBSHITZ, B. M. OSBORNE, M. S. FELDMAN, J. J. MAMEL, and J. M. WEST. 1980. Radiation esophagitis in the opossum: radioprotection with indomethacin. Gastroenterology 78:884-892.
8. NORTHWAY, M. G., G. L. EASTWOOD, H. I. LIBSITZ, M. S. FELDMAN, J. J., MAMEL, and I. A. SZWARC. 1982. Antiinflammatory agents protect opossum esophagus during radiotherapy. Dig. Dis. Sci. 27:923-928.
9. TOCHNER, Z., M. BARNES, and J. B. MITCHELL. 1990. Protection by indomethacin against acute radiation esophagitis. Digestion 47:81-87.
10. TAHA, A. S., S. DAHILL, and Y. NAKSHABENDI. 1992. Lack of papillary elongation and basal cell hyperplasia of the esophageal mucosa in patients receiving NSAIDs. Gut 33:S44.
11. STEIN, B. E., M. L. SCHWARTZMAN, M. A. CARROL, R. E. STAHL, and W. S. ROSENTHALL. 1989. Role of arachidonic acid metabolites in acid-pepsin injury to rabbit esophagus. Gastroenterology 97:278-283.
12. LANAS, A., F. L. SOUSA, J. ORTEGO, F. ESTEVA, J. M. BLAS, J. SORIA, and R. SAINZ. 1995. Aspirin renders the oesophageal mucosa more permeable to acid and pepsin. Ear, J. Gastroenterol. Hepatol. 7:1065-1072.
13. SOFFER, E. E., F. MITROS, F. DOORNBOS, J. FRIEDLAND, J. LOUNSPACH, and R. SUMMERS. 1992. The morphology and pathology of radiation induced esophagitis. A double blind study of naproxen vs placebo for prevention of radiation injury. Gastroenterology 102:A167.
14. LANAS, A., and B. I. HIRSCHOWITZ. 1991. Significant role of aspirin use in patients with esophagitis. J. Clin. Gastroenterol. 13:622-627.
15. HIRSCHOWITZ, B. I. 1996. Gastric acid and pepsin secretion in patients with Barret's esophagus and appropriate controls. Dig. Dis. Sci. 41(7):1384-1391.
16. SAROSIEK, J., Z. YU, Z. NAMIOT, R. M. ROURUK, D. P. HETZEL, and R. W. MCCALLUM. 1994. Impact of acid and pepsin on human esophageal prostaglandins. Am. J. Gastroenterol. 89:588-594.
17. + antiport. Gastroenterology 99:909-917.
18. NAYA, M. J., D. PEREBOOM, J. O. ALDA, and A. LANAS. 1997. Superoxide anion plays an important role in the pathogenesis of acid and pepsin-induced esophagitis in rabbits. Gut 40:175-181.
19. TOBEY, N. A., S. P. REDDY, T. O. KEKU, E. J. CRAGOE, and R. C. ORLANDO. 1992. Studies of pHi in rabbit esophageal basal and squamous epithelial cells in culture. Gastroenterology 103:830-839.
20. POWELL, W. S. 1986. Reversed-phase high-pressure liquid chromatography of araquidonic acid metabolites formed by cycloxigenase and lipoxygenase. Anal. Bioch. 154:332-337.
21. BRADFORD, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
22. SAROSIEK, J., and R. W. MCCALLUM. 1995. Esophagoprotection by prostaglandins: How far are we from reaching the verdict? Am. J. Gastroenterol. 90(5):847-848.
23. SCHMASSMANN, A., A. TARNAWSKI, B. FLOGERZI, M. SANNER, L. VAROA, and F. HALTER. 1993. Dynamics of drug interference with healing of experimental gastric ulcers. Eur. J. Gastroenterol. Hepatol. 5(suppl 3):S13-S20.
24. JESSURUM, J., J. H. YARDLEY, F. M. GIARDIELLO, and S. R. HAMILTON. 1988. Intracytoplasmatic plasma proteins in distended esophageal squamous cells (balloon cells). Modern Pathol. 1:175-181.
25. 2 synthesis by the stomach, and retards gastric emptyung. Life Sci. 48:123-124.